ONLINE SCHEDULING FOR IN-PERSON APPOINTMENTS ONLY!

Please email info@amersimd.com
Skip to main content

Colon Cancer and Women: Why Rates Are Rising and What You Need to Know About Screening and Genetic R

screening

Colon cancer has traditionally been viewed as a disease affecting older adults, but in recent years physicians are seeing a clear rise in diagnoses among younger patients, including women. This shift has changed the way we talk about prevention and early detection. Many women assume that colon cancer is not a concern until much later in life, yet current data shows increasing rates in individuals under fifty. Understanding risk factors, screening guidelines, and the role of genetics is essential for protecting long term health.

There is no single explanation for why colon cancer is rising, but several patterns are likely contributing. Modern dietary habits, chronic stress, metabolic changes, and shifts in the gut microbiome all influence colon health. Higher rates of insulin resistance and chronic inflammation may affect how cells grow and repair within the intestinal lining. Hormonal transitions during perimenopause and menopause are also being studied, as estrogen appears to influence immune signaling and metabolic balance. As hormone levels fluctuate, some women notice changes in digestion, bowel patterns, and overall inflammatory response, which may be part of the broader picture.

Current medical guidelines recommend that average risk adults begin colon cancer screening at age forty five. This change reflects the growing number of early onset cases seen in clinical practice. A colonoscopy is more than a diagnostic test. It is a preventative procedure that allows physicians to identify and remove precancerous polyps before they develop into cancer. Many patients feel well and have no symptoms at the time of screening, which is why age based testing remains one of the most powerful tools we have for prevention.

Genetic testing is another important consideration, especially for women with a family history of colon cancer or related cancers. Conditions such as Lynch syndrome or familial adenomatous polyposis can significantly increase lifetime risk, and identifying these patterns early allows for more personalized screening plans. Genetic evaluation does not replace colonoscopy, but it can help guide when to begin screening and how frequently it should be repeated. Even patients without a strong family history may benefit from discussing genetic risk with their physician if colon cancer occurs at a young age within the family.

Supporting a healthy gut is also an important part of long term colon health. Diets rich in fiber from vegetables, legumes, and whole foods help nourish beneficial bacteria and promote regular bowel function. Staying well hydrated, prioritizing quality sleep, and managing chronic stress all influence the gut microbiome and inflammatory balance. Limiting ultra processed foods, excessive alcohol intake, and prolonged sedentary habits can also reduce strain on the digestive system. Regular physical activity supports healthy motility and metabolic regulation, both of which play a role in maintaining a resilient gastrointestinal environment.

Women should seek medical evaluation sooner if they experience persistent changes in bowel habits, rectal bleeding, unexplained anemia, abdominal discomfort, or unintended weight loss. However, it is important to remember that early colon cancer often causes no symptoms at all. Prevention and early detection remain the most effective strategies for reducing risk.

Colon health is a critical part of preventive medicine. Beginning screening at forty five, understanding personal and genetic risk factors, and supporting daily gut health through lifestyle choices can make a meaningful difference in long term outcomes.

 
Author
Shamsah Amersi, MD

You Might Also Enjoy...

More Than a Label: Reframing Menopause as Recalibration

After two decades as an OB-GYN, I’m reframing menopause and perimenopause as biological recalibration—not decline. Why language matters, how labels shape care, and why women deserve a more empowering, personalized approach to midlife health.

The Brain Is Recalibrating, Not Aging

Emerging research reframes menopause as a neurological and metabolic recalibration—not decline. Learn how hormonal shifts impact brain health, sleep, metabolism, and mood, and how personalized support can help women thrive through this transition.